(NP (NP (NN Dexamethasone) (NN suppression) (NN test)) (: :) (NP (NP (NN corticosteroid) (NNS receptors) (NN regulation)) (PP (IN in) (NP (NP (JJ mononuclear) (NNS leukocytes)) (PP (IN of) (NP (ADJP-COOD (ADJP (JJ young)) (CC and) (ADJP (JJ aged))) (NNS subjects))))) (. .)))
(S (NP-SBJ-7 (NP (DT The) (NN dexamethasone) (NN suppression) (NN test)) (PRN (-LRB- -LRB-) (NP (NN DST)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN considered) (S (NP-SBJ (-NONE- *-7)) (NP-PRD (NP (DT an) (NN indicator)) (PP (IN of) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (DT the) (JJ adrenal) (JJ pituitary) (NN axis))))))))) (. .))
(S (NP-SBJ-8 (NP (DT The) (NN effect)) (PP (IN of) (NP (DT the) (NN steroid)))) (VP (VBZ is) (VP (VBN mediated) (NP (-NONE- *-8)) (PP (IN by) (NP-LGS (NP (PRP$ its) (NN binding)) (PP (TO to) (NP (NN corticosteroid) (NNS receptors))))))) (. .))
(S (NP-SBJ (PRP We)) (ADVP-TMP (RB previously)) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN measurement)) (PP (IN of) (NP (NP (NN corticosteroid) (NNS receptors)) (PP (IN in) (NP (NNS lymphocytes)))))) (VP (VBZ is) (NP-PRD (NP (DT an) (NN index)) (PP (IN of) (NP (NP (DT an) (JJ analogous) (NN pattern)) (PP (IN in) (NP (NN brain)))))))))) (. .))
(S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP-SBJ-9 (NP (NN corticosteroid) (NP-COOD (NP (NN Type) (CD I)) (CC and) (NP (NN Type) (CD II))) (NNS receptors)) (PP (IN in) (NP (JJ mononuclear) (NNS leukocytes)))) (VP (VBD were) (VP (VBN measured) (NP (-NONE- *-9)) (PP-COOD (PP (IN in) (NP (CD 10) (JJ elderly) (NNS subjects))) (CC and) (PP (IN in) (NP (CD 9) (JJ young) (NNS adults)))) (, ,) (PP-TMP (PP-COOD (PP (IN before) (NP (-NONE- *RNR*-10))) (CC and) (PP (IN after) (NP (-NONE- *RNR*-10)))) (NP-10 (NP (JJ overnight) (NN DST)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN mg)) (-RRB- -RRB-)))))) (. .))
(S (NP-SBJ-11 (NNS Receptors)) (VP (VBD were) (VP (VBN measured) (NP (-NONE- *-11)) (PP (IN by) (NP (NN radioreceptor) (NN assay))))) (. .))
(S (PP (IN In) (NP (PDT all) (DT the) (NNS subjects))) (, ,) (NP-SBJ-12 (NN dexamethasone)) (VP (VBD was) (ADJP-PRD (JJ able) (S (NP-SBJ (-NONE- *-12)) (VP (TO to) (VP (VB suppress) (NP (NN plasma) (NN cortisol))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN number)) (PP (IN of) (NP (NP-COOD (NP (NN Type) (CD I)) (CC and) (NP (NN Type) (CD II))) (NNS receptors))) (PP-TMP (IN before) (NP (DT the) (NN test)))) (VP (VBD was) (ADJP-PRD (ADJP (JJR lower)) (PP (-NONE- *ICH*-13))) (PP (IN in) (NP (JJ elderly) (NNS subjects))) (PP-13 (IN than) (FRAG (PP (IN in) (NP (NNS adults)))))) (. .))
(S (S (PP (IN In) (NP (DT the) (NN control) (NN group))) (, ,) (NP-SBJ (NN dexamethasone)) (VP (VBD produced) (NP (NP (DT a) (JJ significant) (NN depression)) (PP (IN of) (NP (NN Type) (CD I) (NNS receptors))) (-LRB- -LRB-) (PP (IN from) (NP (QP (CD 267) (CC (- +)) (CD 72)) (NP (-NONE- *RNR*-14)))) (PP (TO to) (NP (QP (CD 169) (CC (- +)) (CD 71)) (NP (-NONE- *RNR*-14)))) (NP-14 (NP (NNS receptors)) (PP (IN per) (NP (NN cell)))) (-RRB- -RRB-) (, ,) (SBAR (WHNP-15 (WDT which)) (S (NP-SBJ-16 (-NONE- *T*-15)) (VP (MD can) (VP (VB be) (VP (VBN interpreted) (NP (-NONE- *-16)) (PP (IN as) (NP (NP (DT a) (JJ primary) (NN involvement)) (PP (IN of) (NP (NN Type) (CD I) (NNS receptors))) (PP (IN in) (NP (NP (DT the) (NN response)) (PP (TO to) (NP (NN dexamethasone)))))))))))))) (: ;)) (S (NP-SBJ (NN Type) (CD II) (NNS receptors)) (VP (VBD decreased) (PP (IN in) (NP (PDT half) (DT the) (NNS subjects))) (-LRB- -LRB-) (PP (IN from) (NP (QP (CD 2849) (CC (- +)) (CD 703)) (NP (-NONE- *RNR*-17)))) (PP (TO to) (NP (QP (CD 2345) (CC (- +)) (CD 569)) (NP (-NONE- *RNR*-17)))) (NP-17 (NP (NNS receptors)) (PP (IN per) (NP (NN cell)))) (-RRB- -RRB-)) (. .)))
(S (PP (IN In) (NP (JJ elderly) (JJ healthy) (NNS subjects))) (, ,) (NP-SBJ-18 (NN Type) (CD II) (NNS receptors)) (VP (VBD were) (ADVP (RB also)) (VP (ADVP (RB significantly)) (VBN decreased) (NP (-NONE- *-18)) (-LRB- -LRB-) (PP (IN from) (NP (QP (CD 1796) (CC (- +)) (CD 671)))) (PP (TO to) (NP (QP (CD 720) (CC (- +)) (CD 345)))) (-RRB- -RRB-))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (PP (IN in) (NP (JJ young) (NNS subjects))) (NP-SBJ-19 (NN Type) (CD II) (NNS receptors)) (VP (VBP are) (VP-COOD (VP (ADVP-TMP (RB initially)) (VBN up-regulated) (NP (-NONE- *-19)) (PP (IN by) (NP-LGS (NN dexamethasone)))) (, ,) (CC and) (VP (ADVP-TMP (RB then)) (VBN down-regulated) (NP (-NONE- *-19)))) (, ,) (SBAR (IN while) (S (PP (RB in) (NP (JJ aged) (NNS subjects))) (NP-SBJ-20 (DT an) (NN up-regulation)) (VP (MD can) (VP (RB not) (VP (VB be) (NP (-NONE- *-20)) (VBN achieved) (SBAR (, ,) (S (NP-SBJ-22 (-NONE- *)) (VP (IN as) (NP (-NONE- *-22)) (PP (VBN suggested) (NP-LGS (NP (IN by) (DT the) (JJR higher)) (PP (NNS values) (NP (IN of) (NN plasma))) (VP (ADVP-TMP (NN cortisol)) (RB usually) (NP (-NONE- *)) (PP (VBN found) (NP (IN in) (VBG aging)))))))))))))))))) (NNS subjects))
